Select Page

CBDA, an acid form of CBD found in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration. Study published in Toxicology Letters in November 2012.

Cannabinoids: A new hope for breast cancer therapy? Study published in Cancer Treatment Reviews in June 2012.

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Study published in Breast Cancer Research and Treatment in August 2011.

CBD induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Study published in Molecular Cancer Therapeutics in May 2011.

Cannabinoids reduce ErbB2-driven breast cancer progression. Study published in Molecular Cancer in July 2010.

Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Study published in the British Journal of Pharmacology in June 2014.

CBD as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Study published in Molecular Therapeutics Research in November 2007.

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Study published in the Journal of the American Society for Pharmacology and Experimental Therapeutics in May 2006.

THC inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Study published in Cancer Research in July 2006.